Abstract

BackgroundUpadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or intolerance to at...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
POS1041 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC THERAPIES: 2-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 2 STUDY
P J Mease ... X Bu
Annals of the Rheumatic Diseases | VOL. 81
P J Mease, et. al.P J Mease ... X Bu
23 May 2022
Achievement of minimal disease activity in psoriatic arthritis according to the time of administration of synthetic disease-modifying antirheumatic drugs, a comparative analysis of the efficacy of oral and subcutaneous methotrexate. Data from the All-Russian Psoriatic Arthritis Registry
T V Korotaeva ... S S Kudishina
Sovremennaâ Revmatologiâ | VOL. 15
T V Korotaeva, et. al.T V Korotaeva ... S S Kudishina
18 Feb 2021
POS0231 SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR INHIBITORS: RESULTS FROM THE PHASE 3 BE COMPLETE STUDY AND ITS OPEN-LABEL EXTENSION UP TO 1 YEAR
L Coates ... A Asahina
Annals of the Rheumatic Diseases | VOL. 82
L Coates, et. al.L Coates ... A Asahina
30 May 2023
POS0196 UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS REFRACTORY TO BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: 56-WEEK DATA FROM THE PHASE 3 SELECT-PSA 2 STUDY
P J Mease ... A Pangan
-
P J Mease, et. al.P J Mease ... A Pangan
19 May 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigens
Lieve Van Hoovels ... Xavier Bossuyt
Annals of the Rheumatic Diseases | VOL. -
Lieve Van Hoovels, et. al.Lieve Van Hoovels ... Xavier Bossuyt
23 Jul 2024
Early identification of rheumatoid arthritis: does it induce treatment-related cost savings?
Elise Van Mulligen ... Annette Van Der Helm-Van Mil
Annals of the Rheumatic Diseases | VOL. -
Elise Van Mulligen, et. al.Elise Van Mulligen ... Annette Van Der Helm-Van Mil
17 Jul 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severity
Kamini E Kuchinad ... Ami A Shah
Annals of the Rheumatic Diseases | VOL. -
Kamini E Kuchinad, et. al.Kamini E Kuchinad ... Ami A Shah
17 Jul 2024
Altered CD8+ T cell subpopulation in the bone marrow microenvironment of cynomolgus monkeys with spontaneous ankylosing spondylitis
Tangming Guan ... Wende Li
Annals of the Rheumatic Diseases | VOL. -
Tangming Guan, et. al.Tangming Guan ... Wende Li
17 Jul 2024
View more papers